Epidemiology of aflatoxin exposure and human liver cancer

Journal of Toxicology - Toxin Reviews

Volumn 23, Issue 2-3, 2004, Pages 249-271

  Wang, Jia Sheng ^a   Tang, Lili ^a  

^a TEXAS TECH UNIVERSITY   (United States)

Author keywords

Aflatoxin exposure; Epidemiology; Human liver cancer

Indexed keywords

AFLATOXIN; AFLATOXIN B1; BIOLOGICAL MARKER; PROTEIN P53;

AFRICA; ASIA; CASE CONTROL STUDY; COHORT ANALYSIS; GENE MUTATION; GENE TARGETING; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HISPANIC; HUMAN; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MORBIDITY; MORTALITY; NONHUMAN; REVIEW; TUMOR SUPPRESSOR GENE; VIRUS INFECTION;

ANIMALIA; DNA VIRUSES; HEPATITIS B VIRUS; HEPATITIS C VIRUS; PRIMATES; RNA VIRUSES; RODENTIA;

EID: 5344238943     PISSN: 07313837     EISSN: None     Source Type: Journal    
DOI: 10.1081/TXR-200027834     Document Type: Review

References (66)

1. Aguilar, F., Hussain, S. P., Cerutti, P. (1993). Aflatoxin B1 induces the transversion of G-T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 90:8586-8590.
2. Aguilar, F., Harris, C. C., Sun, T., Hollstein, M., Cerutti, P. (1994). Geographic variation of p53 mutational profile in nonmalignant human liver. Science 264:1317-1319.
3. American Cancer Society (1995-2003). Cancer Facts and Figures. Atlanta, GA: American Cancer Society.
4. Beasley, R. (1988). Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer (Phila.) 61:1942-1956.
5. Bressac, B., Kew, M., Wands, J., Ozturk, M. (1991). Selective G to T mutations of p53 gene in hepatocellular carcinoma from Southern Africa. Nature 350:429-431.
6. Bulata-Jayme, J., Almero, E. M., Castro, C. A., Jardeleza, T. R., Salamat, L. (1982). A case-control dietary study of primary liver cancer risk from aflatoxin exposure. Int. J. Epidemiol 11(2):112-119.
7. Busby, W. F. Jr., Wogan, G. N. (1985). Aflatoxins. In: Searle, C. E., ed. Chemical Carcinogens. 2nd ed. Washington, DC: American Chemical Society, pp. 945-1136.
8. Campbell, T. C., Chen, J., Liu, C., Li, J., Parpia, B. (1990). Nonassociation of aflatoxin with primary liver cancer in a cross-sectional ecological survey in the People's Republic of China. Cancer Res. 50:6881-6893.
9. Cerutti, P., Hussain, P., Pourzand, C., Aguilar, F. (1994). Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene. Cancer Res. 54:1934s-1938s.
10. Chen, C. J., Wang, L. Y., Lu, S. N., Wu, M. H., You, S. L., Zhang, Y. L., Wang, L. W., Santella, R. M. (1996). Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology 24:38-42.
11. Coursaget, P., Depril, N., Chabaud, M., Nandi, R., Mayelo, V., LeCann, P., Yvonnet, B. (1993). High prevalence of mutations at codon 249 of p53 gene in hepatocellular carcinomas from Senegal. Br. J. Cancer 67:1395-1397.
12. Eaton, D. L., Groopman, J. D., eds. (1994). The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance. New York: Academic Press.
13. Evans, A. A., OíConnell, A. P., Pugh, J. C., Mason, W. S., Shen, F.-M., Chen, G.-C., Lin, W.-Y., Dia, A., MíBoup, S., Drame, B., London, W. T. (1998). Geographic variation in viral load among hepatitis B carriers with differing risk of hepatocellular carcinoma. Cancer Epidemiol. Biomark. Prev. 7:559-565.
14. Fujimoto, Y., Hampton, L. L., Wirth, P. J., Wand, N. J., Xie, J. P., Thorgeirsso, S. S. (1994). Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res. 54:281-285.
15. Groopman, J. D., Wang, J.-S., Scholl, P. F. (1996). Molecular biomarkers for aflatoxin: from adducts to gene mutations to human liver cancer. Can. J. Physiol. Pharm. 74:203-209.
16. Hatch, M. C., Chen, C. J., Levin, B., Ji, B. T., Yang, G. Y., Hsu, S. W., Wang, L. W., Hsieh, L. L., Santella, R. M. (1993). Urinary aflatoxin levels, hepatitis-B virus infection and hepatocellular carcinoma in Taiwan. Int. J. Cancer 54:931-934.
17. Hsu, I. C., Metcalf, R. A., Sun, T., Wesh, J. A., Wang, N. J., Harris, C. C. (1991). Mutational hotspot in the p53 gene in human hepatocellualr carcinomas. Nature 350:427-428.
18. IARC (1993). Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 56: Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. Lyon: IARC Press, pp. 245-395.
19. IARC (1994). Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 59. Hepatitis Viruses. Lyon: IARC Press, pp. 45-221.
20. IARC (2002). Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 82: Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. Lyon: IARC Press, pp. 171-274.
21. Jackson, P. E., Kuang, S.-Y., Wang, J.-B., Strickland, P. T., Munoz, A., Kensler, T. W., Qian, G.-S., Groopman, J. D. (2003). Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients. Carcinogenesis 24:1657-1663.
22. Kensler, T. W., Qian, G.-S., Chen, J.-G., Groopman, J. D. (2003). Translational strategies for cancer prevention in liver. Nat. Rev., Cancer 3:321-329.
23. Kuang, S.-Y., Fang, X., Lu, P.-X., Zhang, Q.-N., Wu, Y., Wang, J., Zhu, Y.-R., Groopman, J. D., Kensler, T. W., Qian, G.-S. (1996). Aflatoxin-albumin adducts and risk of hepatocellular carcinoma in residents of Qidong, People's Republic of China. Proc. AACR 37:1714.
24. Lasky, T., Magder, L. (1997). Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerprint of aflatoxin exposure? Environ. Health Perspect. 105:392-397.
25. Li, D., Cao, Y., He, L., Wang, N. J., Gu, J. (1993). Aberrations of p53 gene in human hepatocellular carcinoma from China. Carcinogenesis 14:169-173.
26. Li, N.-D., Lu, F.-Z., Zhang, S.-W., Mo, R., Sun, X.-D. (1997). Trends and prediction in malignant tumors mortality in past 20 years in China. Chin. J. Oncol 19:3-9.
27. London, W. T., Evans, A. A., McGlynn, K., Buetow, K., An, P., Gao, L.-L., Lustbader, E., Ross, E., Chen, G.-C., Shen, F.-M. (1995). Viral, host and environmental risk factors for hepatocellular carcinoma: a prospective study in Haimen City, China. Intervirology 38:155-161.
28. Lu, P., Kuang, S., Wang, J., Fang, X., Zhang, Q. N., Wu, Y., Lu, Z. H., Qian, G. L. (1998). Hepatitis B virus infection and aflatoxin exposure in the development of primary liver cancer. Zhonghua Yi Xue Za Zhi (Nat. Med. J. China) 78:340-342. (in Chinese).
29. Lunn, R. M., Langlois, R. G., Hsieh, L. L., Thompson, C. L., Bell, D. A. (1999). XRCCl polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 59:2557-2561.
30. Mandishona, E., MacPhail, A. P., Gordeuk, V. R., Kedda, M. A., Paterson, A. C., Rouault, T. A., Kew, M. C. (1998). Dietary iron overload as risk factor for hepatocellular carcinoma in black Africans. Hepatology 27:1563-1566.
31. 1. Proc. Natl. Acad. Sci. U. S. A. 92:2384-2387.
32. McGlynn, K. A., Hunter, K., LeVoyer, T., Roush, J., Wise, P., Michielli, R. A., Shen, F. M., Evans, A. A., London, W. T., Buetow, K. H. (2003). Susceptibility of aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. Cancer Res. 63:4594-4601.
33. Olubuyide, I. O., Maxwell, S. M., Hood, H., Neal, G. E., Hendrickse, R. G. (1993a). HBsAg, aflatoxins and primary hepatocellular carcinoma. Afr. J. Med. Med. Sci. 22:89-91.
34. Olubuyide, I. O., Maxwell, S. M., Akinyinka, O. O., Hart, C. A., Neal, G. E., Hendrickse, R. G. (1993b). HBsAg and aflatoxins in sera of rural (Igbo-Ora) and urban (Ibadan) populations in Nigeria. Afr. J. Med. Med. Sci. 22:77-80.
35. Omer, R. E., Bakker, M. I., Van't Veer, P., Hoogenboom, R. L. A. P., Polman, T. H. G., Alink, G. M., Idris, M. O., Kadaru, A. M. Y., Kok, F. J. (1998). Aflatoxin and liver cancer in Sudan. Nutr. Cancer 32: 174-180.
36. Omer, R. E., Verhoef, L., Van't Veer, P., Idris, M. O., Kadaru, A. M. Y., Kampaman, E., Bunschoten, A., Kok, F. J. (2001). Peanut butter intake, GSTM1 genotype and hepatocellular carcinoma: a case-control study in Sudan. Cancer Causes Control 12:23-32.
37. Ozturk, M. (1991). P53 Mutation in hepatocellular carcinoma after aflatoxin exposure. The Lancet 338:1356-1359.
38. Parkin, D., Pisani, P., Ferlay, J. (1993). Estimates of the worldwide incidence of 18 major cancers in 1985. Int. J. Cancer 54:594-606.
39. Peers, F. G., Gilman, G. A., Linsell, C. A. (1976). Dietary aflatoxins and human liver cancer. A study in Swaziland. Int. J. Cancer 17:167-176.
40. Peers, F., Bosch, X., Kaldor, J., Linsell, A., Pluijmen, M. (1987). Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int. J. Cancer 39:545-553.
41. Puisieux, A., Lim, S., Groopman, J. D., Ozturk, M. (1991). Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res. 51:6185-6189.
42. Qian, G. S., Yu, M. C., Ross, R., Yuan, J. M., Gao, Y. T., Wogan, G. N., Groopman, J. D. (1994). A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, P.R.C. Cancer Epidemiol. Biomark. Prev. 3:3-11.
43. Rashid, A., Wang, J.-S., Qian, G.-S., Lu, P.-X., Hamilton, S. R., Groopman, J. D. (1999). Genetic alteration in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations. Br. J. Cancer 80:59-66.
44. Ross, R., Yuan, J. M., Yu, M., Wogan, G. N., Qian, G. S., Tu, J. T., Groopman, J. D., Gao, Y. T., Henderson, B. E. (1992). Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. The Lancet 339:943-946.
45. Srivatanakul, P., Parkin, D. M., Jiang, Y. Z., Khlat, M., Kao-Ian, U. T., Sontipong, S., Wild, C. P. (1991a). The role of infection by Opisthorchis viverrini, hepatitis B virus, and aflatoxin exposure in the etiology of liver cancer in Thailand. A correlation study. Cancer 68:2411-2417.
46. Srivatanakul, P., Parkin, D. M., Khlat, M., Chenvidhya, D., Chotiwan, P., Insiriposng, S., L'Abbe, K. A., Wild, C. P. (1991b). Liver cancer in Thailand. A case control study of hepatocellular carcinoma. Int. J. Cancer 48:329-332.
47. Stern, M. C., Umbach, D. M., Yu, M. C., London, S. J., Zhang, Z.-Q., Taylor, J. A. (2001). Hepatitis B, aflatoxin B1, and p53 codon 249 mutation in hepatocellualr carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies. Cancer Epidemiol. Biomark. Prev. 10:617-625.
48. Stoloff, L. (1983). Aflatoxin as a cause of primary liver-cell cancer in the United States: a probability study. Nutr. Cancer 5:165-186.
49. 1. Hepatology 30:379-383.
50. Sun, C. A., Wang, L. Y., Chen, C. J., Lu, S. N., You, S. L., Wang, L. W., Wang, Q., Wu, D. M., Santella, R. M. (2001). Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan. Carcinogenesis 22:1289-1294.
51. Van Rensburg, S. J., Cook-Mozaffari, P., Van Schalkwyk, D. J., Van der Watt, J. J., Vincent, T. J., Purchase, I. F. (1985). Hepatocelluar carcinoma and dietary aflatoxin in Mozambique and Transkei. Br. J. Cancer 51:713-726.
52. Van Rensburg, S. J., Van. Schalkwyk, G. C., Van Schalkwyk, D. J. (1990). Primary liver cancer and aflatoxin intake in Transkei. J. Environ. Pathol. Toxicol. Oncol. 10:11-16.
53. Wang, J.-S., Groopman, J. D. (1999). DNA damage by mycotoxins. Mutat. Res. 424:167-181.
54. Wang, J.-S., Qian, G.-S., Zarba, A., He, X., Zhu, Y.-R., Zhang, B.-C., Jacobson, L., Gange, S. J., Munoz, A., Kensler, T. W., Groopman, J. D. (1996a). Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China. Cancer Epidemiol. Biomark. Prev. 5:253-261.
55. Wang, L. Y., Hatch, M., Chen, C. J., Levin, B., You, S. L., Lu, S. N., Wu, M. H., Wu, W. P., Wang, L. W., Wang, Q., Huang, G. T., Yang, P. M., Lee, H. S., Santella, R. M. (1996b). Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int. J. Cancer 67:620-625.
56. Wang, J.-S., Kensler, T. W., Groopman, J. D. (1998). Toxicants in food: fungal contaminants. In: Ioannides, C., ed. Nutrition and Chemical Toxicity. New York: John Wiley, pp. 29-57.
57. Wang, J.-S., Huang, T., Su, J., Liang, F., Wei, Z., Liang, Y., Luo, H., Kuang, S. Y., Qian, G. S., Sun, G., He, X., Kensler, T. W., Groopman, J. D. (2001). Hepatocellular carcinoma and aflatoxin exposure in Zhuqing village, Fusui County, People's Republic of China. Cancer Epidemiol. Biomark. Prev. 10:143-146.
58. Wild, C. P., Turner, P. C. (2002). The toxicology of aflatoxins as a basis for public health decisions. Mutagenesis 17:471-481.
59. Wogan, G. N. (1992). Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res. 52:2114s-2118s.
60. Yeh, F. S., Shen, K. N. (1986). Epidemiology and early diagnosis of primary liver cancer in China. Adv. Cancer Res. 47:297-329.
61. Yeh, F. S., Mo, C. C., Yen, R. C. (1985). Risk factors for hepatocellular carcinoma in Guangxi, People's Republic of China. Natl. Cancer Inst. Monogr. 69:47-48.
62. Yeh, F. S., Yu, M. C., Mo, C. C., Luo, S., Tong, M. J., Henderson, B. E. (1989). Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi. China Cancer Res. 49:2506-2509.
63. Yu, S. Z. (1995). Primary prevention of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 10:674-682.
64. Yu, M. W., Lien, J. P., Chiu, Y. H., Santella, R. M., Liaw, Y. F., Chen, C. J. (1997). Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. J. Hepatol. 27:320-330.
65. Yu, S. Z., Huang, X. E., Koide, T., Cheng, G., Chen, G. C., Harada, K., Ueno, Y., Sueoka, E., Oda, H., Tashiro, F., Mizokami, M., Ohno, T., Xiang, J., Tokudome, S. (2002). Hepatitis B and C virus infection, lifestyle and genetic polymorphisms as risk factors for hepatocellular carcinoma in Haimen. China Jpn. J. Cancer Res. 93:1287-1292.
66. Yuan, J. M., Govindarajan, S., Henderson, B. E., Yu, M. C. (1996). Low prevalence of hepatitis C infection in hepatocellular carcinoma (HCC) cases and population controls in Guangxi, a hyperendemic region for HCC in the People's Republic of China. Br. J. Cancer 74:491-493.